en
Scientific article
Case report
Open access
English

A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID ‐19 vaccine with a literature review

Published inClinical case reports, vol. 11, no. 5, e7184
Publication date2023-05-16
First online date2023-05-16
Abstract

The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID-19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

eng
Keywords
  • 2019‐nCoV vaccine mRNA‐1273
  • COVID‐19
  • COVID‐19 vaccines
  • Drug‐related side effects and adverse reactions
  • Molecular mechanisms of pharmacological action
  • Rhabdomyolysis
Citation (ISO format)
SHEKA, Maria et al. A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID ‐19 vaccine with a literature review. In: Clinical case reports, 2023, vol. 11, n° 5, p. e7184. doi: 10.1002/ccr3.7184
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2050-0904
63views
10downloads

Technical informations

Creation06/09/2023 7:49:35 AM
First validation07/04/2023 12:31:38 PM
Update time07/04/2023 12:31:38 PM
Status update07/04/2023 12:31:38 PM
Last indexation05/06/2024 4:40:26 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack